FoxM1 is regarded as an oncogenic transcription factor and aberrant activation of FoxM1 is considered to be associated with the proliferation and metastasis of human CRC cells.[10–12,16] Some studies reported that FoxM1 might act as an independent role in diagnosis and prognosis of CRC.[19,20] However, individual trials were limited to insufficient specimens and different experimental environments. This evidence concerns the gene FOXM1 and colorectal carcinoma.